3 completed, 1 not yet recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Eyevensys: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy PST-611 - Geographic Atrophy, Age - Related Macular Degeneration (AMD) | Phase 2 | Not yet recruiting | Eyevensys | 24 | 2026-09-01 | 2026-07-16 |
| A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration PST-611 - Dry Age Related Macular Degeneration | Phase 1 | Completed | Eyevensys | 8 | 2025-06-23 | 2026-07-13 |
| A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) EYS606 - Non-infectious Uveitis | Phase 2 | Completed | Eyevensys | 3 | 2020-02-03 | 2022-03-10 |
| Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis pEYS606 - Non-infectious Uveitis | Phase 1 / Phase 2 | Completed | Eyevensys | 15 | 2017-04-04 | 2022-03-10 |
Geographic Atrophy (1) · Macular Degeneration (1) · Uveitis (1)
France (3) · United Kingdom (1) · United States (1)
2025 (1)